Atlas Trials

Oncolytic Virus Plus PD-1 Inhibitor to Patients With Advanced Pancreatic Cancer

Clinical trial NCT06196671 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06196671
Sponsor
Fudan University
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2026-12-01
Primary completion
2028-01-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.